Year: 2020

news_6

Multi-Lingual Support From the Global MediXchange of Combating COVID-19 (GMCC) Programme to Further Enable Sharing Among Medical Personnel Worldwide

HANGZHOU, China--(BUSINESS WIRE)--Over 440 medical institutions from 104 countries and regions have applied to learn and share experiences in battling...

news_6

Qurient Announces Publication in New England Journal of Medicine of Phase 2 Data for Telacebec, a First-in-Class Antibiotic for the Treatment of Tuberculosis

Clinical data supports continued development of telacebec toward the first universal regimen to overcome tuberculosis regardless of drug resistance status...